Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
Scientists at Gladstone Institutes in San Francisco have provided hope for a treatment for type 1 diabetes by developing a technique to reprogram skin cells into insulin-producing beta cells.
In a potential breakthrough for the treatment of type 1 diabetes, researchers have successfully turned mouse skin cells into insulin-producing beta cells.
Could a cure for type 1 diabetes be in sight? Scientists discover how to turn ordinary skin cells into those that produce insulin
A diabetes cure could be in sight after scientists transformed ordinary skin cells into pancreatic cells producing insulin.
Gladstone Investigator Sheng Ding weighs in on a surprising study finding that a simple acid bath might turn cells in the body into stem cells that could one day be used for tissue repair and other medical treatments.
Gladstone Investigators Shinya Yamanaka and Sheng Ding weigh in on findings tha an external stressor, such as low pH or a mechanical squeeze, can send differentiated mouse cells back to a pluripotent state.
A close look inside the researchers and laboratory of Gladstone Investgiator Steve Finkbeiner—and their search for a cure for devastating diseases of the brain.
Scientists in the US have pinpointed the so-called Achilles heel of the AIDS virus. The findings could lead to the development of a new therapeutic strategy for the treatment of HIV - one which targets the host, rather than the virus.
In uncontrolled HIV infection, an over-the-top immune response causes much of the damage that leads to AIDS, researchers are reporting.
HIV infection causes a mass suicide of immune cells — a process that can be halted by an experimental drug that blocks cellular self-destruction, studies in cell cultures suggest. Researchers are now proposing a clinical trial of the drug in people with HIV.